Calvin Pohl

Calvin Pohl is a highly skilled Principal Scientist at AbbVie, specializing in immunology with a focus on PK/PD and biomarker development since June 2018. Prior to this role, Calvin served as a Senior Scientist II and a Postdoctoral Fellow, where efforts centered on utilizing primate models and in vivo pharmacology to study inflammatory bowel disease. Calvin's academic background includes a PhD in Comparative Medicine and Integrative Biology from Michigan State University, complemented by a Doctor of Veterinary Medicine from Purdue University and a BA in Liberal Arts and Sciences from Wabash College.